SCHEMBL1493594

SCHEMBL1493594

C#CS(=O)(=O)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7058429 0.78
SCHEMBL9148563 0.67
SCHEMBL18297993 0.65
SCHEMBL2705095 0.65
SCHEMBL5712311 0.64
SCHEMBL5159472 0.64
SCHEMBL27775958 0.64
SCHEMBL3411437 0.62
SCHEMBL17074232 0.60
Methanesulfonamide SCHEMBL7880249 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4132650-B1 DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS UCB Biopharma SRL (BE) 2024-06-12 EP claimed
WO-2011033225-A2 SUBSTITUTED 3-AMINO-CINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-24 WO claimed
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP claimed
EP-1379577-B1 CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES SOLUTIA INC (US) 2004-08-25 EP claimed
EP-0832082-B1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ASTRAZENECA AB (SE) 2001-11-21 EP claimed
EP-0752986-B1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LTD (GB) 1999-05-19 EP claimed
EP-0348736-B1 SUBSTITUTED THIADIAZOLYLOXY ACETAMIDES BAYER AG (DE) 1992-11-11 EP claimed
WO-2011033225-A2 SUBSTITUTED 3-AMINO-CINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-24 WO disclosed
WO-2010031735-A1 PIPERAZINE D3 AND 5-HT2A RECEPTOR MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2010-03-25 WO disclosed